Press Releases

AdvaMed Applauds President’s Focus on Testing, Vaccination

AdvaMed Applauds President’s Focus on Testing, Vaccination

WASHINGTON, D.C. AdvaMed, the world’s leading trade association for medical technology companies—which includes the diagnostics companies that make Covid-19 tests—released the following statement from president and CEO Scott Whitaker:

“We applaud the President and his Administration for recognizing the critical roles regular testing and widespread vaccination serve in bringing the pandemic under control. We look forward to continuing to work closely with the Administration to further extend the reach of quality testing, strengthening our public-private collaboration and coordination. Our diagnostic companies, as they have been from the beginning of this crisis, are fully committed to supporting our nation’s Covid response. Our industry has been leading the way, to ensure our employees and contractors are either vaccinated or regularly tested. It’s critically important to keep facilities open and ensure they remain as safe as possible so that the important work of manufacturing the medical technologies patients rely on can continue.”

Last week, AdvaMedDx – the division within AdvaMed that serves diagnostics manufacturers – sent a letter with the American Clinical Laboratory Association (ACLA) to the White House offering a number of policy recommendations to help the diagnostic testing industry continue to meet the challenges presented by the pandemic. The recommendations included:

# # #

AdvaMed member companies produce the medical devices, diagnostic products and digital health technologies that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit